Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other Non-Current Liabilities (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Other Non-Current Liabilities data on record, last reported at $1.2 million in Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 33.45% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, up 33.45%, while the annual FY2025 figure was $1.2 million, 33.45% up from the prior year.
  • Other Non-Current Liabilities reached $1.2 million in Q4 2025 per ORGO's latest filing, down from $2.5 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $3.7 million in Q1 2021 and bottomed at $894000.0 in Q4 2024.
  • Average Other Non-Current Liabilities over 5 years is $1.5 million, with a median of $1.2 million recorded in 2025.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 88.78% in 2021, then skyrocketed 138.33% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $1.6 million in 2021, then dropped by 27.94% to $1.1 million in 2022, then increased by 8.11% to $1.2 million in 2023, then dropped by 26.3% to $894000.0 in 2024, then skyrocketed by 33.45% to $1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $1.2 million in Q4 2025, $2.5 million in Q3 2025, and $3.0 million in Q2 2025.